News Detail
New Delhi, 25 Feb 2025: The Central Drugs Standard Control Organization (CDSCO) has issued a final notice to manufacturers of certain pre-1988 permitted Fixed Dose Combinations (FDCs), urging them to submit applications for Phase IV Clinical Trial protocols or Active Post Ma......
View Details
Source : DrugsControl Media Services
Central Drugs Standard Control Organization (CDSCO)
Fixed Dose Combinations (FDCs)
Phase IV Clinical Trial protocols
Active Post Marketing Surveillance
Related News
- Karnataka notifies NDPS Rules, Essential Narcotic Drugs to be regulated under Central Rules (22-03-2025)
- One hundred teams participated in 'Operation Garuda', uncovering nearly 40 different types of drugs being sold without prescriptions (22-03-2025)
- List of OTC drugs to be Submitted to Govt Soon: Panel Chief (21-03-2025)
- DCA seized four medicines for misleading 'Leucoderma', 'Tuberculosis' and 'Fever' treatment claims (21-03-2025)
- Skin specialists flag widespread quackery in Kerala (21-03-2025)
- SHRC orders criminal proceedings against fake doctor (21-03-2025)
- Gujarat HC stays GST action against Gujarat Medical Council, other boards (21-03-2025)
- CEPI and AstraZeneca to advance discovery into novel antibody (21-03-2025)
- FIR against 3 animal husbandry dept officials booked for sending damaged vaccine to Hospitals (21-03-2025)
- Eli Lilly launches blockbuster anti-obesity drug Mounjaro in India (20-03-2025)